{"id":"W2600523014","doi":"10.3389/fonc.2017.00052","title":"Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine","year":2017,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Bevacizumab; Erlotinib; Nintedanib; Lung cancer; Context (archaeology); Oncology; Immunotherapy; Personalized medicine; Ramucirumab; Nivolumab; Angiogenesis; Internal medicine; Cancer; Chemotherapy; Overall survival; Bioinformatics; Lung; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003405808,0.0002651559,0.002114007,0.0002414555,0.00006878595,0.00000479617,0.0002198003,0.0002822817,0.00003203973],"category_scores_gemma":[0.00004189051,0.000159981,0.0002276449,0.0001558994,0.0002369814,0.0000285949,0.00001831782,0.0002319323,1.980608e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004897204,"about_ca_system_score_gemma":0.001104179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003552207,"about_ca_topic_score_gemma":0.0001577448,"domain_scores_codex":[0.9987044,0.0001143503,0.0005117958,0.0003217458,0.0001014441,0.0002462072],"domain_scores_gemma":[0.9988475,0.0002213268,0.0004804404,0.0003509682,0.00005952683,0.00004021668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001770131,0.0001417208,0.002016963,0.006007046,0.0005392076,0.00003210526,0.00245195,7.959056e-7,0.000004480804,0.00001149015,0.004025355,0.9845919],"study_design_scores_gemma":[0.008307975,0.0005440933,0.0005056447,0.009015354,0.002537393,0.00002185826,0.0006264698,0.00003023501,0.000001487522,0.00002674372,0.97824,0.000142808],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001983559,0.9931386,0.0004911182,0.0009290948,0.0009083746,0.003277779,0.00009933687,0.000004700595,0.0009526992],"genre_scores_gemma":[0.00006721705,0.9924048,0.00458428,0.0002193937,0.0001533081,0.001704866,0.000100157,0.0000396601,0.0007263077],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9844491,"threshold_uncertainty_score":0.6523836,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03738282497124096,"score_gpt":0.4364721285986241,"score_spread":0.3990893036273831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}